Alpha Tau to Participate in Citi’s 2024 Global Healthcare Conference and Piper Sandler’s 36th Annual Healthcare Conference
2024年11月13日 - 10:30PM
Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ:
DRTS, DRTSW), the developer of the innovative alpha-radiation
cancer therapy Alpha DaRT®, today announced
that CFO Raphi
Levy will participate in the Citi 2024
Global Healthcare Conference on December 3rd, 2024 and the Piper
Sandler 36th Annual Healthcare Conference on December 5th, 2024.
Event: |
Citi 2024 Global Healthcare Conference |
Format: |
1-on-1 Meetings |
Date: |
December 3, 2024 |
Time: |
8:30AM – 4:30PM EST |
Location: |
Miami, FL |
Event: |
Piper Sandler 36thAnnual Healthcare Conference |
Format: |
Fireside Chat and 1-on-1 Meetings |
Date: |
December 5, 2024 |
Time: |
10:00-10:25AM EST |
Location: |
New York, NY |
Please reach out to your Citi and Piper Sandler representatives
to schedule 1-on-1 meetings with Mr. Levy.
About Alpha Tau Medical Ltd.
Founded in 2016, Alpha Tau is an Israeli oncology therapeutics
company that focuses on research, development, and potential
commercialization of the Alpha DaRT for the treatment of solid
tumors. The technology was initially developed by Prof. Itzhak
Kelson and Prof. Yona Keisari from Tel Aviv University.
About Alpha DaRT ®
Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) is
designed to enable highly potent and conformal alpha-irradiation of
solid tumors by intratumoral delivery of radium-224 impregnated
sources. When the radium decays, its short-lived daughters are
released from the sources and disperse while emitting high-energy
alpha particles with the goal of destroying the tumor. Since the
alpha-emitting atoms diffuse only a short distance, Alpha DaRT aims
to mainly affect the tumor, and to spare the healthy tissue around
it.
Investor Relations Contact: IR@alphatau.com
Alpha Tau Medical (NASDAQ:DRTS)
過去 株価チャート
から 11 2024 まで 12 2024
Alpha Tau Medical (NASDAQ:DRTS)
過去 株価チャート
から 12 2023 まで 12 2024